Granted Patent B2

US 12,364,537 · App. 18/145,449 · Granted Jul 22, 2025

Inventor: Virender K. Sharma (Paradise Valley, AZ)

A61B18/1492A61B18/04A61B90/39A61M25/1018A61B5/0538A61B5/6853A61B2017/00026A61B2017/00044A61B2017/00053A61B2017/00084A61B2017/00243A61B2017/00274A61B2017/00809A61B2017/00818A61B2017/4216A61B2018/00023A61B2018/00244A61B2018/00285A61B2018/00357A61B2018/00488A61B2018/00494A61B2018/005A61B2018/00541A61B2018/00547A61B2018/00559A61B2018/00577A61B2018/00642A61B2018/00744A61B2018/00791A61B2018/00821A61B2018/00839A61B2018/00863A61B2018/048A61B2090/064A61B2090/0811A61B2090/3925A61B2090/3966A61M2205/3368

Abstract

Claims (29)

1. A method of ablating cardiac tissue comprising:

positioning a distal end of a catheter proximate cardiac tissue, wherein the catheter comprises:

an outer shaft having a first lumen extending from a proximal end of the catheter to a first point positioned before the distal end of the catheter;

an inner shaft having a second lumen extending from the proximal end of the catheter to a second point at or before the distal end of the catheter, wherein the inner shaft is positioned within the outer shaft;

a balloon positioned between said first point and said second point; and

a vapor channel extending through said second lumen, wherein the vapor channel is in fluid communication with the balloon;

activating a controller to inflate said balloon with air to cause said balloon to inflate to a first pressure; and

activating the controller to cause vapor to pass from the vapor channel into the balloon.

2. The method of claim 1 further comprising determining an area of the cardiac tissue associated with an arrhythmia using a plurality of sensors positioned at a distal end of the catheter.

3. The method of claim 2 wherein determining an area of the cardiac tissue associated with an arrhythmia further comprises using a mapping membrane coupled with the outer shaft or the inner shaft at a location distal to the balloon, wherein the mapping membrane is configured to map the area of cardiac tissue associated with the arrhythmia.

4. The method of claim 3 wherein the mapping membrane comprises a radial extension catheter.

5. The method of claim 3 wherein the mapping membrane comprises a substrate having a plurality of sensors, detectors, or electrodes.

6. The method of claim 2 wherein determining an area of the cardiac tissue associated with an arrhythmia further comprises using a first mapping balloon coupled to the distal end of the catheter configured to map an area of the cardiac tissue associated with an arrhythmia.

7. The method of claim 6 further comprising inflating the mapping balloon with water or air, wherein a length of the inflated mapping balloon is greater than a length of the balloon filled with vapor and wherein a diameter of the balloon filled with vapor is approximately equivalent to a diameter of the inflated mapping balloon.

8. The method of claim 1 wherein activating the controller to cause vapor to pass from the vapor channel into the balloon causes the balloon to inflate to a second pressure, wherein the second pressure is different from the first pressure.

9. The method of claim 8 further comprising, using the controller, causing an amount of air to be removed from said balloon to maintain said second pressure within a range of 25% of said first pressure.

10. The method of claim 8 further comprising, using the controller, modulating an amount of vapor passing into the balloon to maintain said second pressure within a range of 25% of said first pressure.

11. The method of claim 1 further comprising applying said balloon containing the vapor to the cardiac tissue.

12. The method of claim 11 wherein applying said balloon containing the vapor to the cardiac tissue further comprises transferring heat from the vapor in the balloon to the cardiac tissue via a hot zone of the balloon.

13. The method of claim 12 further comprising causing the hot zone of the balloon to contact an area of the cardiac tissue associated with an arrhythmia.

14. The method of claim 1 further comprising activating the controller to cause water to pass from a water source into at least one of the outer shaft and inner shaft.

15. The method of claim 1 further comprising activating the controller to cause water to pass from a water source into both the outer shaft and inner shaft.

16. The method of claim 1 further comprising:

inflating a mapping balloon with a fluid, wherein the mapping balloon is coupled to the distal end of the catheter, the mapping balloon comprises one or more mapping electrodes, a length of the inflated mapping balloon is greater than a length of the balloon filled with vapor, and a diameter of the balloon filled with vapor is approximately equivalent to a diameter of the inflated mapping balloon; and

using the inflated mapping balloon to map an area of the cardiac tissue associated with an arrhythmia.

17. The method of claim 16 further comprising activating the controller to cause the balloon to inflate to a second pressure greater than the first pressure.

18. The method of claim 17 further comprising ablating the cardiac tissue at an area where the balloon contacts the cardiac tissue, wherein the balloon has a surface area and wherein a portion of that surface area that is warmer than a remaining portion of that surface area.

19. The method of claim 18 further comprising monitoring tissue impedance and tissue temperature by using mapping electrodes.

20. The method of claim 18 further comprising performing pacing distal to the mapping balloon to determine an adequacy of ablation.

Continuity (6)

References Cited (400)